P Turco
Overview
Explore the profile of P Turco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dal Negro R, Turco P, Povero M
Respir Med
. 2018 Jul;
141:144-149.
PMID: 30053960
Objectives: Influenza and Influenza-like syndromes (I-LSs) are very common events in general practice, and their relevance is frequently underestimated. Aim of the study was to assess the economic impact of...
2.
Dal Negro R, Bonadiman L, Turco P
Multidiscip Respir Med
. 2015 Aug;
10(1):24.
PMID: 26246895
Background: Several comorbidities frequently affect COPD progression. Aim of the study was to assess the prevalence of main comorbidities by gender and disease severity in a cohort of COPD patients...
3.
Dal Negro R, Visconti M, Turco P
Pulm Pharmacol Ther
. 2015 Jun;
33:47-51.
PMID: 26116425
Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with increased airway and systemic inflammation. There is evidence that erdosteine accelerates recovery from AECOPD by reducing airway inflammation....
4.
Confortini M, Di Stefano C, Biggeri A, Bulgaresi P, Di Claudio G, Grisotto L, et al.
Cytopathology
. 2014 Aug;
27(1):35-42.
PMID: 25123613
Objective: An important internal quality control system used in the Cancer Prevention and Research Institute cytopathology laboratory in Florence is the peer review procedure, based on the review of all...
5.
Dal Negro R, Bonadiman L, Micheletto C, Tognella S, Turati C, Turco P
Pulm Pharmacol Ther
. 2011 Mar;
24(4):373-6.
PMID: 21421072
Unlabelled: Chronic obstructive pulmonary disease (COPD) is a complex and progressive respiratory disease characterized by incompletely reversible bronchial obstruction. The effects of current therapeutic options in early stages of COPD...
6.
Dal Negro R, Tognella S, Tosatto R, Dionisi M, Turco P, Donner C
Respir Med
. 2007 Sep;
102(1):92-101.
PMID: 17881206
Chronic respiratory diseases affect a large number of subjects in Italy and are characterized by high socio-health costs. The aim of the Social Impact of Respiratory Integrated Outcomes (SIRIO) study...
7.
Dal Negro R, Micheletto C, Tosatto R, Dionisi M, Turco P, Donner C
Respir Med
. 2007 Sep;
101(12):2511-9.
PMID: 17822890
Bronchial asthma is a costly disease and the correlated social impact is ever increasing. The aim of the Social Impact of Respiratory Integrated Outcomes (SIRIO) study was to measure the...
8.
Dal Negro R, Micheletto C, Tognella S, Turati C, Bisato R, Guerriero M, et al.
Monaldi Arch Chest Dis
. 2007 Aug;
67(2):84-9.
PMID: 17695691
Background And Aim: Subjects with airway obstruction are strongly recommended to monitor their lung function, which is particularly variable in asthma. Unlike PEFR, other personal measurements (such as FEV1) are...
9.
Dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L
Allergy
. 2003 Sep;
58(10):1018-22.
PMID: 14510719
The aim of the present study was to assess the dose-dependency from inhaled steroids of changes of airways inflammation [eosinophils count and eosinophil cationic protein (ECP)] measures in induced sputum...
10.
Carozzi F, Cariaggi M, Bonardi L, Bulgaresi P, Cecchini S, Ciatto S, et al.
Diagn Cytopathol
. 2003 Jun;
29(1):4-7.
PMID: 12827706
The cost-effectiveness of qualifying ASCUS cases into two different subcategories, favoring a reactive (ASCUS-R) or dysplastic process (ASCUS-S), was evaluated at the Centro per lo Studio e la Prevenzione Oncologica...